Company news
CNBX Pharmaceuticals Inc. news in 2022
CNBX Pharmaceuticals Inc.'s news releases, calls and decks from 2022, newest first.
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma
November 8, 2022
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy
October 18, 2022
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel
October 13, 2022
CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate
September 29, 2022
CNBX Pharmaceuticals Announces New Patent Granted in Australia
September 28, 2022
CNBX Pharmaceuticals Release a New Corporate Presentation
May 31, 2022
CNBX Pharmaceuticals Granted Patent in Hong Kong
May 5, 2022
Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals
March 28, 2022